Concepedia

Jonathan M. Yingling

JM

Statistics

Publications

34

Citations

4.3K

H-Index

26

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

Vanderbilt University

Duke University

University of Wisconsin Carbone Cancer Center

Vall d'Hebron Institute of Oncology

Jonathan M. Yingling is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and radiation oncology.

Top concepts

Publications per year

1992–2017

34

Publications

34

TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma

Judit Anido, Andrea Sáez‐Borderías, Alba Gonzàlez-Juncà et al. · Cancer Cell · 2010 · 569 citations · Full text

, , +10

Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development

Molly Weaver, Jonathan M. Yingling, N. Ray Dunn et al. · Development · 1999 · 334 citations

A Transforming Growth Factor β Type I Receptor that Signals to Activate Gene Expression

Craig H. Bassing, Jonathan M. Yingling, David J. Howe et al. · Science · 1994 · 290 citations

Tumor Suppressor Smad4 Is a Transforming Growth Factor β-Inducible DNA Binding Protein

Jonathan M. Yingling, Michael Datto, Carolyn Wong et al. · Molecular and Cellular Biology · 1997 · 272 citations · Full text

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

J. Scott Sawyer, Bryan D. Anderson, Douglas W. Beight et al. · Journal of Medicinal Chemistry · 2003 · 237 citations · Full text

, , +20

1–5 of 34